Enovis Corp
ENOV
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.5B
Close$
$-12.87
152% downside
Current Fair Value
152% downsideOvervalued by 152% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.50 Billion |
|---|---|
| Enterprise Value | $2.86 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-20.86 |
| Beta | 1.45 |
| Outstanding Shares | 57,600,973 |
Return
| Return on Equity | -74.59% |
|---|---|
| Return on Assets | -29.25% |
| Return on Invested Capital | -33.32% |
Valuation & Multiples
| P/E Ratio | -1.34 |
|---|---|
| PEG | 1.36 |
| Price to Sales | 0.63 |
| Price to Book Ratio | 0.99 |
| Enterprise Value to Revenue | 1.25 |
| Enterprise Value to EBIT | -2.72 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | 0.93 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$0.85
Average shareholder expectationRevenue Estimate
$581.84 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.77
Average shareholder expectationRevenue Estimate
$558.47 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0507▲ 2.56% |
|---|---|
| Total Calls | 2,376,880▼ 14.30% |
| Total Puts | 120,500▲ 72.88% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 125.30%▲ 7.19% |
|---|---|
| Total Invested | $1.47B▼ 3.51% |
| Investors Holding | 256▼ 5.00% |
ESG Score
No data
About Enovis Corp
15,400 employees
CEO: Matthew Trerotola Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...